Abstract:DOC-2/DAB2 interacting protein (DAB2IP) is a RasGAP protein that shows a suppressive effect on cancer progression. Our previous study showed the involvement of transcription regulation of DAB2IP in metastasis of colorectal cancer (CRC). However, the molecular mechanisms of DAB2IP in regulating the progression of CRC need to be further explored. Here, we identified heterogeneous nuclear ribonucleoprotein K (hnRNPK) and matrix metalloproteinase 2 (MMP2) as vital downstream targets of DAB2IP in CRC cells by two-d… Show more
“…Considering that DAB2IP plays a critical role in regulating the activation of ERK1/2 pathway in colorectal cancer [ 13 , 31 ] and activation of ERK1/2 signaling pathway contributes to tumor cell growth and metastasis [ 21 – 23 ], we asked whether DAB2IP modulates the growth and metastasis of gastric cancer cells via regulating ERK1/2 signaling pathway. In accordance with other studies [ 13 , 31 ], blockade of DAB2IP enhanced the phosphorylation of ERK1/2 in gastric cancer cells ( Figure 5(a) ) and the enhanced proliferation and migration ability induced by DAB2IP knockdown was remarkably reduced after incubation with U0126 in SGC7901 gastric cancer cells (Figures 5(c) and 5(d) ). Furthermore, EMT induced by DAB2IP knockdown was reversed after treatment with U0126 in both AGS and SGC7901 gastric cancer cells ( Figure 5(b) ).…”
DAB2IP (DOC2/DAB2 interactive protein) is downregulated in several cancer types, and its downregulation is involved in tumor cell proliferation, apoptosis, metastasis, and epithelial-mesenchymal transition (EMT). We aimed to investigate the potential role of DAB2IP in the development and progression of gastric cancer. DAB2IP levels were analyzed in human gastric cancer and adjacent normal tissues by Western blots and immunohistochemistry. Potential roles of DAB2IP in regulating gastric cancer cell growth and metastasis were examined by genetic manipulation in vitro. The molecular signaling was determined to understand the mechanisms of observed DAB2IP effects. DAB2IP level is lower in gastric cancer tissues as compared to paired normal tissues. Knockdown of DAB2IP enhanced gastric cancer cell growth and metastasis in vitro and promoted EMT progress at both protein and mRNA levels. Silencing DAB2IP activated extracellular signal-regulated kinase 1/2 (ERK1/2) pathway, and the enhanced proliferation and migration ability induced by DAB2IP knockdown were reduced after incubation with U0126 in SGC7901 gastric cancer cells. Inhibition of DAB2IP enhances gastric cancer cell growth and metastasis through targeting the ERK1/2 signaling, indicating that it may serve as a potential target for treatment of gastric cancer.
“…Considering that DAB2IP plays a critical role in regulating the activation of ERK1/2 pathway in colorectal cancer [ 13 , 31 ] and activation of ERK1/2 signaling pathway contributes to tumor cell growth and metastasis [ 21 – 23 ], we asked whether DAB2IP modulates the growth and metastasis of gastric cancer cells via regulating ERK1/2 signaling pathway. In accordance with other studies [ 13 , 31 ], blockade of DAB2IP enhanced the phosphorylation of ERK1/2 in gastric cancer cells ( Figure 5(a) ) and the enhanced proliferation and migration ability induced by DAB2IP knockdown was remarkably reduced after incubation with U0126 in SGC7901 gastric cancer cells (Figures 5(c) and 5(d) ). Furthermore, EMT induced by DAB2IP knockdown was reversed after treatment with U0126 in both AGS and SGC7901 gastric cancer cells ( Figure 5(b) ).…”
DAB2IP (DOC2/DAB2 interactive protein) is downregulated in several cancer types, and its downregulation is involved in tumor cell proliferation, apoptosis, metastasis, and epithelial-mesenchymal transition (EMT). We aimed to investigate the potential role of DAB2IP in the development and progression of gastric cancer. DAB2IP levels were analyzed in human gastric cancer and adjacent normal tissues by Western blots and immunohistochemistry. Potential roles of DAB2IP in regulating gastric cancer cell growth and metastasis were examined by genetic manipulation in vitro. The molecular signaling was determined to understand the mechanisms of observed DAB2IP effects. DAB2IP level is lower in gastric cancer tissues as compared to paired normal tissues. Knockdown of DAB2IP enhanced gastric cancer cell growth and metastasis in vitro and promoted EMT progress at both protein and mRNA levels. Silencing DAB2IP activated extracellular signal-regulated kinase 1/2 (ERK1/2) pathway, and the enhanced proliferation and migration ability induced by DAB2IP knockdown were reduced after incubation with U0126 in SGC7901 gastric cancer cells. Inhibition of DAB2IP enhances gastric cancer cell growth and metastasis through targeting the ERK1/2 signaling, indicating that it may serve as a potential target for treatment of gastric cancer.
“…On the other hand, no association between variant in rs7025486 and the incidence of CAD was observed, while the GWAS and replicating study consistently found the effects of a common variant in DAB2IP (rs7025486) on the development of CAD and other complications [ 12 , 26 , 27 ]. In cancer cells, DAB2IP, as a Ras-GTPase, exerted a suppressive effect on tumor invasion and maintained chromosomal stability [ 13 , 14 , 28 ]. However, the molecular mechanisms of DAB2IP in regulating the progression of atherosclerosis need further investigation.…”
BackgroundOur study aims to explore the association of rs7025486 single-nucleotide polymorphisms (SNP) in DAB2IP and rs1333049 on chromosome 9p21.3 with the coronary artery disease in Chinese population.MethodsAll patients came from the east China area and underwent coronary angiography. Rs7025486 and rs1333049 polymorphism were genotyped in 555 patients with CAD and in 480 healthy controls that underwent coronary angiography.ResultsIn Chinese population, the rs7025486 genotype in the case group was no significant different than the control group (P = 0.531).Meanwhile, the rs1333049 SNP has statistically significant (P = 0.006), which was the independent risk factors for CAD (OR1.252, P = 0.039), and consistent with the past studies conclusion.ConclusionGenotype of rs1333049 on chromosome 9p21, but not rs7025486 on chromosome 9q33, is an independent determinant of the incidence of CAD in Chinese population.
“…As aged cells are downregulated in their expression of collagen IV [ 83 ], this may lead to more efficient BM degradation in the aged host. Additionally, in many cancers, Dab2 downregulation leads to increased transcription of the ribonucleoprotein hnRNPK, which then enhances MMP2 transcription by the metastatic cells [ 91 ]. Thus, downregulation of Dab2, as observed in OvCa metastatic cell lines, may be correlated with increased MMP2 expression.…”
Section: Aging Modifies the Metastatic Microenvironmentmentioning
Age is one of the biggest risk factors for ovarian cancer. Older women have higher rates of diagnosis and death associated with the disease. In mouse models, it was shown that aged mice had greater tumor burden than their younger counterparts when intraperitoneally injected with ovarian tumor cells. While very few papers have been published looking at the direct link between ovarian cancer metastasis and age, there is a wealth of information on how age affects metastatic microenvironments. Mesothelial cells, the peritoneal extracellular matrix (ECM), fibroblasts, adipocytes and immune cells all exhibit distinct changes with age. The aged peritoneum hosts a higher number of senescent cells than its younger counterpart, in both the mesothelium and the stroma. These senescent cells promote an inflammatory profile and overexpress Matrix Metalloproteinases (MMPs), which remodel the ECM. The aged ECM is also modified by dysregulated collagen and laminin synthesis, increases in age-related crosslinking and increasing ovarian cancer invasion into the matrix. These changes contribute to a vastly different microenvironment in young and aged models for circulating ovarian cancer cells, creating a more welcoming “soil”.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.